ProPhase Labs shareholders approve share increase to 1B and equity plans

ProPhase Labs, Inc.

Shareholders approved increase in authorized common shares from 50M to 1B at Sept 9 special meeting.
Approved amendments to 2022 equity plan and 2025 equity plan, enabling executive participation.
Warrants to CEO Ted Karkus and an investor for 500k shares each now fully exercisable.
Company can now reserve 400% of shares for conversion of July 2025 20% OID notes and warrants.
Bylaw amendment to update principal office address approved.

item 1.01item 5.02item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.